As a Cornell professor under a small grant from Defense Advanced Research Projects Agency (DARPA), Dr. McQuade synthesized ibuprofen using continuous flow chemistry. This was the science that showed creating a Pharmacy on Demand (PoD) platform was possible and thus was the basis of the DARPA PoD project. He was a DARPA project manager who oversaw the PoD project. He previously served as Chief Technology Officer for the Bill & Melinda Gates Foundation-funded Medicines for All Institute in Richmond, VA, and as a professor of both chemistry and chemical engineering at numerous universities. Dr. McQuade earned his PhD in Chemistry at the University of Wisconsin and completed his post-doctorate research at the Massachusetts Institute of Technology as an NIH Post-Doctoral Fellow.